Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03688165Completed

The Effects of Gait Rehabilitation After Stroke by Treadmill-based Robotics Versus Traditional Gait Training

Role: collaborator

NCT01146587Not ApplicableSuspended

Comparative Study of GangTrainer GT1, Lokomat and Conventional Physiotherapy

Role: collaborator

NCT01467960Unknown

Apolipoprotein D (ApoD) In Human Serum As Marker Of Parkinson's Disease

Role: lead

All 3 trials loaded